Please use this identifier to cite or link to this item: http://repo.knmu.edu.ua/handle/123456789/5326
Title: Medical genetics. Contents module 4. Monogenic diseases. Disorders of amino acid metabolism
Authors: Grechanina, E.Y.
Grechanina, Y.B.
Molodan, L.V.
Zdubskaya, E.P.
Bugayova, E.V.
Keywords: Inherited metabolic diseases
amino acids
phenylketonuria
hyperphenylalaninemia
Tyrosinemia
Albinism
Issue Date: 2013
Publisher: Kharkiv National Medical University
Citation: Medical genetics. Contents module 4. Monogenic diseases. Disorders of amino acid metabolism : guidelines for students and interns / comp.: E. Y. Grechanina, Y. B. Grechanina, L. V. Molodan, E. P. Zdubskaya, E. V. Bugayova ; Kharkiv National Medical University. – Kharkiv : KhNMU, 2013. – 23 p.
Abstract: General laws of pathogenesis. Schematically, the principal chains of pathogenesis of monogenic diseases can be represented as follows: mutant alleles → pathological primary product (qualitatively or quantitatively changed), a chain of biochemical subsequent processes → cell → bodies→ body. This is the basic pattern of monogenic diseases in all their diversity. Phenylketonuria (PKU) is the most common metabolic defect of phenylalanine (amino-acid). In a normal condition, phenylalanine (PhA) is decomposed via tyrosine pathway. Phenylalanine hydroxylase or tetrahydrobiopterin (its cofactor) deficient leads to PhA accumulation in biological liquids of the body. There are several clinically and biochemically heterogenic forms of PKU. Classical phenylketonuria is a disease caused by a mutation in the phenylalanine hydroxylase gene (PAH) localized on 12q24. 100 mutations are localized in PAH, including substitutions, insertions, deletions. Inheritance type is autosomal reccesive (AR). Diseases are developed as a result of the interaction of great amount of PhA and the products of its metabolism (phenyl-pyruvic, phenylacetic, phenyl-lactic acids, phenylethylamine and other) on the body, and these products accumulate in the body as a result of a full of partial absence of phenylalanine hydroxylase enzyme. PhA and its metabolites inhibit biochemical processes necessary for normal brain development: protein metabolism, glycol - and lipoprotein metabolism, AA transport, hormone metabolism, causing disorders of nervous system myelination in children, liver parenchyma lesions and other metabolic disorders.
URI: http://repo.knmu.edu.ua/handle/123456789/5326
Appears in Collections:Навчально-методичні видання. Кафедра медичної генетики

Files in This Item:
File Description SizeFormat 
Disorders of amino acid metabolism, for students.doc126,5 kBMicrosoft WordView/Open


This item is protected by original copyright



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.